To explore the visual acuity and anatomic outcomes over 24 months of patients with diabetic macular edema (DME) who showed a delayed anatomic response after 3 ranibizumab injections in the RIDE and RISE trials.


Read full article on AAO Journal


Powered by Preisvergleich


WVAEPS Members

Member Login